Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion type Assertion NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_head.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion description "[After in vitro stimulation with the respective peptides, CTLs directed against VP1(p44) were more abundant than against VP1(p108) in most healthy individuals, while the converse was true in KTx recipients with PVN, suggesting a shift in epitope immunodominance in the setting of active BKV infection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_provenance.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion evidence source_evidence_literature NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_provenance.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion SIO_000772 16537617 NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_provenance.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion wasDerivedFrom befree-20140225 NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_provenance.
- NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_assertion wasGeneratedBy ECO_0000203 NP266094.RAldbEe9ZEW4rAjNpud4KCOui1LfnS9u4q_swT9Uw7kAE130_provenance.